The prevalence of peanut and tree nut allergy in the USA has increased, especially in the pediatric population. Nut allergy remains the leading cause of fatal anaphylactic reactions. Management of anaphylaxis includes not only treatment of symptoms during a reaction, but strict dietary avoidance and education on potential situations, which may place the patient at high risk for accidental exposure. Cross-reactivity between various nuts along with various cross-contamination sources should be discussed with all nut-allergic individuals. Exciting research continues to emerge on other potential treatments for patients allergic to nuts, including allergen immunotherapy. Results of such interventions have been encouraging, though further studies are needed regarding safety and long-term outcomes before these can be applied to clinical practice.
CITATION STYLE
Lomas, J. M., & Järvinen, K. M. (2015, October 29). Managing nut-induced anaphylaxis: Challenges and solutions. Journal of Asthma and Allergy. Dove Medical Press Ltd. https://doi.org/10.2147/JAA.S89121
Mendeley helps you to discover research relevant for your work.